Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Huntsman

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2018
Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and OntarioBryn Lander, Elizabeth Wilcox, Jessica N McAlpine, et al.
Annals of Surgery|May 21, 2010
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patientsConnie G Chiu, Hamid Masoudi, Samuel Leung, et al.
Genes, Chromosomes & Cancer|April 22, 2004
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinomaNikita Makretsov, May He, Malcolm Hayes, et al.
Histopathology|October 22, 2013
Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation statusNaveena Singh, C Blake Gilks, David G Huntsman, et al.
Breast Cancer Research and Treatment|July 29, 2009
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancersLindsay A Brown, Karynn Johnson, Samuel Leung, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomasWilko Weichert, Carsten Denkert, Aurelia Noske, et al.
Breast Cancer Research : BCR|January 16, 2008
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility studySimon J Crabb, Chris D Bajdik, Samuel Leung, et al.
American Journal of Clinical Pathology|July 2, 2002
Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarrayRobin L Parker, David G Huntsman, David W Lesack, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 21, 2005
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probeJefferson Terry, Todd S Barry, Douglas E Horsman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 22, 2010
Differences in tumor type in low-stage versus high-stage ovarian carcinomasMartin Köbel, Steve E Kalloger, David G Huntsman, et al.
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2018
Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and OntarioBryn Lander, Elizabeth Wilcox, Jessica N McAlpine, et al.
Annals of Surgery|May 21, 2010
HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patientsConnie G Chiu, Hamid Masoudi, Samuel Leung, et al.
Genes, Chromosomes & Cancer|April 22, 2004
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinomaNikita Makretsov, May He, Malcolm Hayes, et al.
Histopathology|October 22, 2013
Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation statusNaveena Singh, C Blake Gilks, David G Huntsman, et al.
Breast Cancer Research and Treatment|July 29, 2009
Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancersLindsay A Brown, Karynn Johnson, Samuel Leung, et al.
Neoplasia (New York, N.Y.)|August 21, 2008
Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomasWilko Weichert, Carsten Denkert, Aurelia Noske, et al.
Breast Cancer Research : BCR|January 16, 2008
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility studySimon J Crabb, Chris D Bajdik, Samuel Leung, et al.
American Journal of Clinical Pathology|July 2, 2002
Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarrayRobin L Parker, David G Huntsman, David W Lesack, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 21, 2005
Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probeJefferson Terry, Todd S Barry, Douglas E Horsman, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 22, 2010
Differences in tumor type in low-stage versus high-stage ovarian carcinomasMartin Köbel, Steve E Kalloger, David G Huntsman, et al.
Pageof 32